nanoparticle universal influenza vaccine (UniFlu) / Emergent Biosolutions - LARVOL DELTA

EBS-UFV-001: Universal Influenza A Vaccine in Healthy Adults (clinicaltrials.gov) - P1 | N=27 | Completed | Sponsor: Emergent BioSolutions | Active, not recruiting ➔ Completed | N=60 ➔ 27 | Trial completion date: Apr 2024 ➔ Oct 2023

Enrollment change • Trial completion • Trial completion date • Infectious Disease • Influenza • Respiratory Diseases

EBS-UFV-001: Universal Influenza A Vaccine in Healthy Adults (clinicaltrials.gov) - P1 | N=60 | Active, not recruiting | Sponsor: Emergent BioSolutions | Recruiting ➔ Active, not recruiting | Trial primary completion date: Apr 2023 ➔ Oct 2023

Enrollment closed • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases